Douglas Calder
Net worth: 18 748 $ as of 2026-09-29
Net worth: 18 748 $ as of 2026-09-29
Mr. Douglas W.
Calder is an Independent Director at Lunai Bioworks, Inc., an Independent Director at Zevra Therapeutics, Inc. and a Member at Society For Natural Immunity.
He is on the Board of Directors at Lunai Bioworks, Inc., Zevra Therapeutics, Inc., Nextgennk and BioFlorida, Inc. Mr. Calder was previously employed as a President & Director by Vycellix, Inc., a Director-Investor Relations & Public Relations by Accentia Biopharmaceuticals, Inc., a VP-Strategic Planning & Capital Markets by BioVest International, Inc., a Portfolio Manager by Dean Witter Reynolds, Inc., a Portfolio Manager by Gruntal & Co. LLC, an Executive Vice President by Pulse Evolution Corp., and a President by VyGen-Bio, Inc. He received his undergraduate degree from Florida State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0.25% | 2026-10-12 | 12,754 ( 0.25% ) | 18 748 $ | 2026-09-29 |
| 2026-06-03 | 0 ( -.--% ) | - $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director/Board Member | 2023-04-24 |
Nextgennk | Director/Board Member | 2019-05-31 |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Director/Board Member | 2018-12-31 |
| Companies | Position | End |
|---|---|---|
| LUNAI BIOWORKS INC. | Director/Board Member | 2026-10-21 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Investor Relations Contact | 2013-07-15 |
| ACCENTIA BIOPHARMACEUTICALS INC | Investor Relations Contact | 2013-03-03 |
Dean Witter Reynolds, Inc.
Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Corporate Officer/Principal | - |
Gruntal & Co. LLC
Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Lunai Bioworks, Inc.
Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Pulse Evolution Corp.
Pulse Evolution Corp. Information Technology ServicesTechnology Services Produces photorealistic digital humans and provides digital production | Technology Services |
Dean Witter Reynolds, Inc.
Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Finance |
Gruntal & Co. LLC
Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
Vycellix, Inc.
Vycellix, Inc. BiotechnologyHealth Technology Engages in the development of transformational platform technologies for cell & gene-based therapies | Health Technology |
Nextgennk | |
VyGen-Bio, Inc.
VyGen-Bio, Inc. BiotechnologyHealth Technology Develops cell & gene therapies and treatments for cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions